The international and intercontinental spread and expansion of antimicrobial-resistant Salmonella Typhi: a genomic epidemiology study
Background The emergence of increasingly antimicrobial-resistant Salmonella enterica
serovar Typhi (S Typhi) threatens to undermine effective treatment and control. Understanding …
serovar Typhi (S Typhi) threatens to undermine effective treatment and control. Understanding …
Association between erectile dysfunction and type 2 diabetes mellitus
D Tamrakar, DS Bhatt, VK Sharma, AK Poudyal… - 2021 - elibrary.nhrc.gov.np
Background: Erectile dysfunction is a distressing complication of diabetes among male
patients. Despite being a serious concern affecting sexual health, the issue regarding sexual …
patients. Despite being a serious concern affecting sexual health, the issue regarding sexual …
Global diversity and antimicrobial resistance of typhoid fever pathogens: Insights from a meta-analysis of 13,000 Salmonella Typhi genomes
Background: The Global Typhoid Genomics Consortium was established to bring together the
typhoid research community to aggregate and analyse Salmonella enterica serovar Typhi (…
typhoid research community to aggregate and analyse Salmonella enterica serovar Typhi (…
Estimating typhoid incidence from community-based serosurveys: a multicohort study
…, N Alam, FN Zahan, MS Kabir, D Tamrakar… - The Lancet …, 2022 - thelancet.com
Background The incidence of enteric fever, an invasive bacterial infection caused by typhoidal
Salmonellae (Salmonella enterica serovars Typhi and Paratyphi), is largely unknown in …
Salmonellae (Salmonella enterica serovars Typhi and Paratyphi), is largely unknown in …
Incidence of typhoid and paratyphoid fever in Bangladesh, Nepal, and Pakistan: results of the Surveillance for Enteric Fever in Asia Project
…, TY Alexander, K Vaidya, D Tamrakar… - The Lancet Global …, 2022 - thelancet.com
Background Precise enteric fever disease burden data are needed to inform prevention and
control measures, including the use of newly available typhoid vaccines. We established the …
control measures, including the use of newly available typhoid vaccines. We established the …
Spatial heterogeneity of enteric fever in 2 diverse communities in Nepal
D Tamrakar, K Vaidya, AT Yu, K Aiemjoy… - Clinical Infectious …, 2020 - academic.oup.com
Background Typhoid fever is endemic in the urban Kathmandu Valley of Nepal; however, there
have been no population-based studies of typhoid outside of this community in the past 3 …
have been no population-based studies of typhoid outside of this community in the past 3 …
High rates of enteric fever diagnosis and lower burden of culture-confirmed disease in peri-urban and rural Nepal
…, K Vaidya, C Bern, D Tamrakar… - The Journal of …, 2018 - academic.oup.com
Background In South Asia, data on enteric fever are sparse outside of urban areas. We
characterized enteric fever diagnosis patterns and the burden of culture-confirmed cases in peri-…
characterized enteric fever diagnosis patterns and the burden of culture-confirmed cases in peri-…
Safety and immunogenicity of conjugate vaccine for typhoid (Vi-DT): Finding from an observer-blind, active-controlled, randomized, non-inferiority, phase III clinical …
D Tamrakar, P Poudel, P Thapa, S Singh… - Human Vaccines & …, 2024 - Taylor & Francis
Typhoid fever is a significant public health concern with most of the sufferers between 15
and 25 y of age in Nepal. We undertook this study to demonstrate Vi polysaccharide …
and 25 y of age in Nepal. We undertook this study to demonstrate Vi polysaccharide …
Efficacy of a monovalent (D614) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, multi-country study
…, N Sirisuphmitr, T Starkey, K Suzuki, D Tamrakar… - …, 2023 - thelancet.com
Background The literature on first generation COVID-19 vaccines show they were less effective
against new SARS-CoV-2 variants of concern including Omicron (BA.1, BA.2, BA.4 and …
against new SARS-CoV-2 variants of concern including Omicron (BA.1, BA.2, BA.4 and …
Efficacy of a bivalent (D614+ B. 1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, parallel, randomised, modified double-blind …
…, A Siika, C Singh, VB Singh, D Tamrakar… - The Lancet …, 2023 - thelancet.com
Background COVID-19 vaccines with alternative strain compositions are needed to provide
broad protection against newly emergent SARS-CoV-2 variants of concern. This study aimed …
broad protection against newly emergent SARS-CoV-2 variants of concern. This study aimed …
